Transient Babinski sign after electroconvulsive therapy (ECT).

J ECT

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY Departments of Psychiatry and Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, NY Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY

Published: December 2014

Download full-text PDF

Source
http://dx.doi.org/10.1097/YCT.0000000000000126DOI Listing

Publication Analysis

Top Keywords

transient babinski
4
babinski sign
4
sign electroconvulsive
4
electroconvulsive therapy
4
therapy ect
4
transient
1
sign
1
electroconvulsive
1
therapy
1
ect
1

Similar Publications

Background: Sarcoidosis, a multisystem inflammatory non-caseating granulomatous disease, can present with neurologic lesions in up to 10% of patients.

Case Description: A 57-year-old male presented with three months of worsening upper extremity radicular pain associated with dysmetria, hyperreflexia, bilateral Hoffman's, and positive Babinski signs. The contrast magnetic resonance imaging (MRI) showed a diffuse T2 signal hyperintensity and T1-enhancing 2.

View Article and Find Full Text PDF
Article Synopsis
  • In utero exposure to maternal antibodies against fetal acetylcholine receptors can cause severe conditions like arthrogryposis multiplex congenita (AMC) and the milder fetal acetylcholine receptor inactivation syndrome (FARIS), but the full impact remains unclear.
  • A study of 46 cases reveals that many affected mothers did not have prior diagnoses of myasthenia gravis, suggesting underreporting and missed preventative measures.
  • Among the findings, significant long-term effects in surviving infants included various physical weaknesses, respiratory issues, and unexpected conditions like hearing loss; treatment with oral salbutamol showed promising improvement in symptoms for many children.
View Article and Find Full Text PDF

Background: Contrast-induced encephalopathy (CIE) is a rare transient, reversible abnormality in the structure or function of the nervous system caused by the intravascular use of contrast agents. CIE can present with a range of neurological manifestations, including focal neurological deficits (hemiplegia, hemianopia, cortical blindness, aphasia, and parkinsonism) and systemic symptoms (confusion, seizures, and coma). However, if not accurately diagnosed and treated in a timely manner, CIE can cause irreversible damage to patients, especially critically ill patients.

View Article and Find Full Text PDF

Background: The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification.

Methods And Results: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank country income classification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!